510(k) device
SPEAC System
Brain Sentinel, Inc. · Physiological Signal Based Seizure Monitoring System (POS, Class II) · First FDA decision May 11, 2019, newest Feb 6, 2021Epilepsy
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
2
510(k) pathway
Device trials
7
Naming "SPEAC"
MAUDE reports
0
Brand "SPEAC", since 2015
PubMed studies
15
Mentioning "SPEAC"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing SPEAC System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 2 of 2 decisions filed under this name.
- SPEAC System510(k)
K200276 · Decided Feb 6, 2021 · 368 days after receipt
Device type: Physiological Signal Based Seizure Monitoring System (POS) · Neurology & Neurosurgery
- SPEAC System510(k)
K182180 · Decided May 11, 2019 · 271 days after receipt
Device type: Physiological Signal Based Seizure Monitoring System (POS) · Neurology & Neurosurgery
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "SPEAC", any status and sponsor, newest update first.
Brain SentinelAcademic, hospital or other
NCT03741205 · 40 participants (planned) · Start Jul 1, 2020 · Primary completion Jan 2021
Device: SPEAC System · For: Epilepsy
- Detecting PNES With Single-channel sEMGStatus unknown
Brain SentinelAcademic, hospital or other
NCT03313362 · 71 participants · Start Nov 3, 2017 · Primary completion Jun 21, 2019
Device: SPEAC System; video EEG · For: Epilepsy, Motor Partial; Psychogenic Seizures
Sites: Durham, North Carolina; Houston, Texas; Richmond, Virginia
- Clinical Utility of the SPEAC® System: A Case SeriesStatus unknown
Brain SentinelAcademic, hospital or other
NCT03484598 · 26 participants · Start Sep 1, 2018 · Primary completion Sep 30, 2019
Device: SPEAC System · For: Epilepsy
Sites: Tampa, Florida; Austin, Texas; Dallas, Texas
4 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "SPEAC", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code POS
4 reports: 2 malfunction, 2 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "SPEAC"[tiab]. The summary above synthesizes these.
- Single-cell A/B testing for cell-cell communication.
Aamodt CM, Lewis NE · Cell Syst · 2023Research Support, N.I.H., Extramural
- Droplet-based forward genetic screening of astrocyte-microglia cross-talk.
Wheeler MA, Clark IC, Lee HG, et al. · Science · 2023
- Using real-time, anonymous staff feedback to improve staff experience and engagement.
Frampton A, Fox F, Hollowood A, et al. · BMJ Qual Improv Rep · 2017
- Droplet-based functional CRISPR screening of cell-cell interactions by SPEAC-seq.
Faust Akl C, Linnerbauer M, Li Z, et al. · Nat Protoc · 2025Review, Research Support, Non-U.S. Gov't
- Differentiation of Epileptic and Psychogenic Nonepileptic Seizures Using Single-Channel Surface Electromyography.
Husain AM, Towne AR, Chen DK, et al. · J Clin Neurophysiol · 2021
- Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines.
Lambert PH, Ambrosino DM, Andersen SR, et al. · Vaccine · 2020Consensus Statement, Research Support, Non-U.S. Gov't
- A template tool for the evaluation of vaccines for emerging pathogens to be used for pregnant and breast-feeding women.
Munoz FM, Kampmann B, Stergachis A, et al. · Vaccine · 2025Review
- Seizure detection devices for use in antiseizure medication clinical trials: A systematic review.
Kurada AV, Srinivasan T, Hammond S, et al. · Seizure · 2019Systematic Review
- Thrombosis with thrombocytopenia syndrome (TTS) and vaccine-induced immune thrombocytopenia and thrombosis (VITT): Brighton Collaboration case definitions and guidelines for data collection, analysis, and presentation of immunisation safety data.
Schönborn L, Pavord S, Chen VMY, et al. · Vaccine · 2024
- Molecular evolution of the lysine biosynthetic pathways.
Velasco AM, Leguina JI, Lazcano A · J Mol Evol · 2002Research Support, Non-U.S. Gov't
- Study of a PST-trained voice-enabled artificial intelligence counselor for adults with emotional distress (SPEAC-2): Design and methods.
Ronneberg CR, Lv N, Ajilore OA, et al. · Contemp Clin Trials · 2024Clinical Trial Protocol, Research Support, N.I.H., Extramural
- Acute intraocular inflammation: Brighton Collaboration case definition and guidelines for data collection, analysis, and presentation of immunization safety data.
Yeh S, Mathenge W, Mwanza JC, et al. · Vaccine · 2026
Other devices of this type
Also filed under product code POS.
- EpiMonitorEmpatica S.r.l. · 510(k) 2025
- EmbraceEmpatica S.r.l. · 510(k) 2018
- Nelli (Version 7.11)Neuro Event Labs OY · 510(k) 2025
- NightWatch+ USLivassured BV · 510(k) 2025
- EpiWatch Monitoring SystemEpiwatch, Inc. · 510(k) 2025
- CompanionLgch, Inc. · De Novo 2017
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.